Skip to main content

Advertisement

SpringerLink
Log in

Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Residual disease (RD) has been described as one of the most relevant prognostic factors after radical surgical resection for incidental gallbladder cancer (IGC). The purpose of the present study was to analyze patterns of RD and determinant prognostic factors in patients undergoing re-resection for IGC.

Methods

Patients undergoing re-exploration due to IGC between 1990 and 2014 were identified in two referral centers from different South-American countries. Patients submitted to a radical definitive operation were included in the study. Demographics and tumor-treated related variables were analyzed in correlation with RD and survival. The site of RD, local (gallbladder bed) or regional (lymph nodes and bile duct) was correlated with disease-specific survival (DSS).

Results

Of 265 patients with IGC submitted to surgery, 168 underwent a radical re-resection and RD was found in 58 (34.5%). Demographic, clinical and surgical variables were compared between both centers showing differences in type of resection, laparoscopic approach, T stages and disease stage. Location of RD was regional in 34 (20.2%) and local in 24 (14.3%), and no residual disease was found in 110 (65.5%) patients. T stage (T1b = 20%, T2 = 23.8%, T3 = 71.7%, p < 0.001) and disease stage (p < 0.001) were independent predictors of RD. Finding RD at any location reduced the DSS in comparison with non-RD patients (19.6 months vs. 62.7 months p < 0.001). No differences in DSS according to the location of RD were found, and all anatomic sites were equally poor (p = 0.27). RD at any site predicted DSS (p < 0.001), independently of all other IGC variables.

Conclusions

IGC presented similar clinical parameters in two different countries of South America. RD was demonstrated as the most critical prognostic variable in patients with IGC treated by a radical resection. The presence of RD was associated with poor outcome, independently of any anatomic location. Future studies incorporating neoadjuvant chemotherapy in the treatment of patients with prognostic factors for RD are required to improve survival in this entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lendoire JC, Gil L, Duek F et al (2012) Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) 14(8):548–553

    Article  Google Scholar 

  2. Butte JM, Waugh E, Meneses M et al (2010) Incidental gallbladder cancer: analysis of surgical findings and survival. J Surg Oncol 102(6):620–625

    Article  PubMed  Google Scholar 

  3. Maker AV, Butte JM, Oxenberg J et al (2012) Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol 19(2):409–417

    Article  PubMed  Google Scholar 

  4. Goetze TO, Paolucci V (2010) Adequate extent in radical re-resection of incidental gallbladder carcinoma: analysis of the German Registry. Surg Endosc 24(9):2156–2164

    Article  PubMed  Google Scholar 

  5. Smith GCS, Parks RW, Madhavan KK et al (2003) A 10-year experience in the management of gallbladder cancer. HPB (Oxford) 5(3):159–166

    CAS  Google Scholar 

  6. Fuks D, Regimbeau JM, Le Treut Y-P et al (2011) Incidental gallbladder cancer by the AFC-GBC-2009 study group. World J Surg 35(8):1887–1897. https://doi.org/10.1007/s00268-011-1134-3

    Article  PubMed  Google Scholar 

  7. Ito H, Ito K, D’Angelica M et al (2011) Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 254(2):320–325

    Article  PubMed  Google Scholar 

  8. Pawlik TM, Gleisner AL, Vigano L et al (2007) Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 11(11):1478–1487

    Article  PubMed  Google Scholar 

  9. Gil L, Lendoire J, Duek F et al (2014) Cirugía radical en el cáncer de vesícula incidental: valor del hallazgo de enfermedad residual en el estudio histopatológico diferido. Cir Esp 92(3):168–174

    Article  PubMed  Google Scholar 

  10. Butte JM, Kingham TP, Gönen M et al (2014) Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer. J Am Coll Surg 219(3):416–429

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ethun CG, Postlewait LM, Le N et al (2017) Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival. JAMA Surg 152(2):143

    Article  PubMed  PubMed Central  Google Scholar 

  12. Edge SB, Byrd DR, Compton CC et al (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York

    Google Scholar 

  13. Arroyo GF, Gentile A, Parada LA (2016) Gallbladder cancer: South American experience. Chin Clin Oncol 5(5):67

    Article  PubMed  Google Scholar 

  14. Pitt SC, Jin LX, Hall BL et al (2014) Incidental gallbladder cancer at cholecystectomy. Ann Surg 260(1):128–133

    Article  PubMed  Google Scholar 

  15. Yip VS, Gomez D, Brown S et al (2014) Management of incidental and suspicious gallbladder cancer: focus on early referral to a tertiary centre. HPB 16(7):641–647

    Article  PubMed  Google Scholar 

  16. Tsirlis T, Ausania F, White SA et al (2015) Implications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancer. Ann R Coll Surg Engl 97(2):131–136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Sternby Eilard M, Lundgren L, Cahlin C et al (2017) Surgical treatment for gallbladder cancer—a systematic literature review. Scand J Gastroenterol 52(5):505–514

    Article  PubMed  Google Scholar 

  18. Aloia TA, Járufe N, Javle M et al (2015) Gallbladder cancer: expert consensus statement. HPB 17(8):681–690

    PubMed  Google Scholar 

  19. Ethun CG, Postlewait LM, Le N et al (2017) A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium. Ann Surg Oncol 24(5):1343–1350

    Article  PubMed  Google Scholar 

  20. Shindoh J, de Aretxabala X, Aloia TA et al (2015) Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer. Ann Surg 261(4):733–739

    Article  PubMed  PubMed Central  Google Scholar 

  21. Adsay NV, Bagci P, Tajiri T et al (2012) Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol 29(3):127–141

    Article  PubMed  Google Scholar 

  22. Roa I, Ibacache G, Muñoz S et al (2014) Gallbladder cancer in Chile: pathologic characteristics of survival and prognostic factors: analysis of 1366 cases. Am J Clin Pathol 141(5):675–682

    Article  PubMed  Google Scholar 

  23. Butte JM, Gönen M, Allen PJ et al (2011) The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 13(7):463–472

    Article  Google Scholar 

  24. Creasy JM, Goldman DA, Gonen M et al (2017) Predicting residual disease in incidental gallbladder cancer: risk stratification for modified treatment strategies. J Gastrointest Surg 21(8):1254–1261

    Article  PubMed  PubMed Central  Google Scholar 

  25. Birnbaum DJ, Viganò L, Russolillo N et al (2015) Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio. Ann Surg Oncol 22(3):811–818

    Article  PubMed  Google Scholar 

  26. Shibata K, Uchida H, Iwaki K et al (2009) Lymphatic invasion: an important prognostic factor for stages T1b–T3 gallbladder cancer and an indication for additional radical resection of incidental gallbladder cancer. World J Surg 33(5):1035–1041. https://doi.org/10.1007/s00268-009-9950-4

    Article  PubMed  Google Scholar 

  27. Sirohi B, Mitra A, Jagannath P et al (2015) Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol 11(10):1501–1509

    Article  CAS  PubMed  Google Scholar 

  28. Engineer R, Goel M, Chopra S et al (2016) Neoadjuvant chemoradiation followed by surgery for locally advanced gallbladder cancers: a new paradigm. Ann Surg Oncol 23:3009–3015

    Article  PubMed  Google Scholar 

  29. Matsuda T, Matsuda A, Birnbaum DJ et al (2015) Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis. Ann Surg Oncol 22(3):299–305

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver and Transplant Division, Hospital Dr. Cosme Argerich, Almirante Brown 240, 1155, Buenos Aires, Argentina

    Luis Gil, Javier Lendoire, Fernando Duek & Oscar Imventarza

  2. Department of Surgery, Clínica Alemana, Santiago, Chile

    Xabier de Aretxabala & Juan Hepp

Authors
  1. Luis Gil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xabier de Aretxabala
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Javier Lendoire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fernando Duek
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Hepp
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Oscar Imventarza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luis Gil.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gil, L., de Aretxabala, X., Lendoire, J. et al. Incidental Gallbladder Cancer: How Residual Disease Affects Outcome in Two Referral HPB Centers from South America. World J Surg 43, 214–220 (2019). https://doi.org/10.1007/s00268-018-4762-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-018-4762-z

Search

Navigation